Borislava Ananieva
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
Rasmus Møgelvang is the Chief Executive Officer (CEO) of Rigshospitalet, a highly specialised hospital in Copenhagen.
Rasmus is a physician and a medical specialist in cardiology, and he has previously worked as a consultant at the Department of Cardiology at Rigshospitalet. In 2009, he earned his PhD at the University of Copenhagen, and he was then attached to the Faculty of Health and Medical Sciences as a research associate professor. In 2018, he became a professor in cardiology at the University of Southern Denmark.
Rasmus moved from the clinic to management in 2019, when he was appointed as the Centre Director of the Heart Centre at Rigshospitalet. In 2021, he was appointed as the Deputy Chief Executive of the hospital. He took over as Chief Executive on January 1st, 2023.
Rasmus is a member of the national Life Science Advisory Board, that is established by the Danish government. He has initiated the new Nordic University Hospital Alliance with CEOs from the university hospitals of the Nordic capitals, and he has co-initiated the recent establishment of the Technical University Hospital, a cooperation between the Danish Technical University and the hospitals in Eastern Denmark.
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
Strategic Partnerships Senior Manager, European Patients' Forum (EPF)
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, The European Alcohol Policy Alliance (Eurocare)
Executive Director, Innovative Health Initiative Joint Undertaking
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board & Youth Group Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Director of Operations, Cyprus Federation of Patients’ Associations (CyFPA) and Board Treasurer, European Patients' Forum (EPF)
Board Member, European Patients' Forum (EPF) and Secretary General, Greek Patients' Organisation
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Director Government Affairs & Policy Medtech EMEA, Johnson & Johnson
Executive Director, European Patients' Academy on Therapeutic Innovation (EUPATI)
Deputy Director-General, Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection, Austria
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Board Chair, Czech National Association of Patient Organizations (NAPO) & Board Member, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
Youth Group Member, European Patients' Forum (EPF)
President, European Liver Patient Association (ELPA)
Professor, Sorbonne University
Regional Adviser Control of Antimicrobial Resistance, World Health Organisation/Europe (WHO/Europe)
Director HTA, National Agency for Regional Healthcare Services (AGENAS) and Co-Chair, HTA Member State Coordination Group (HTACG)
Youth Group Member, European Patients' Forum (EPF)
Director, Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
Scientific Lead, Gustave Roussy
Vice President and Head of International Market Access, MSD International Business GmbH
CEO, Rigshospitalet
Director, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
Senior Advisor, Representation Office to the European Union, World Health Organization (WHO)
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Head of Global Patient Engagement, Boehringer Ingelheim
European Affairs Advisor, France Assos Santé
Senior Expert, DG HERA, European Commission
Executive Director, Biomed Alliance in Europe
SVP International, Butterfly Network Inc
Director General, Association of the European Self-Care Industry (AESGP)
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Olivér Várhelyi, Commissioner for Health and Animal Welfare, European Commission
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Regional Head of Innovation, NHS Greater Glasgow and Clyde (NHSGGC)
Policy Officer, European Patients' Forum (EPF)
PhD, MBA. Secretary of the Board at Health Technology Assessment international (HTAi).
Policy Officer, European Patients' Forum (EPF)
CEO, European Multiple Sclerosis Platform (EMSP) and Board Vice President, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)